April Salama, M.d.

This study is testing a new two-drug combination for people with advanced melanoma that has continued to grow despite receiving standard immunotherapy. Researchers want to find a safe dose and see if adding an oral drug called dapansutrile to the existing drug pembrolizumab can h…